title: Monoamine concentrations changes in the PTU-induced hypothyroid rat brain and the ameliorating role of folic acid.
abstract: Thyroid hormones are recognized as the key metabolic hormones that play a critical role in the development of central nervous system (CNS) throughout life. The present study was designed to determine the changes in brain monoamine concentrations in 6-n-propyl thiouracil (PTU)-induced hypothyroid rats, in addition to the ameliorating role of folic acid treatment. Fifty male albino rats were equally divided into five groups; first and second groups were the control and folic acid groups, respectively, while the third group was the hypothyroid group in which the rats received PTU in drinking water for 6 weeks. The fourth and fifth groups were co- and post-treated folic acid groups with hypothyroid rats, respectively. Our results revealed that serotonin and norepinephrine concentrations were significantly decreased in the hypothalamus and cortex, while it significantly increased in the hippocampus of hypothyroid rats when compared with control group. Serotonin and norepinephrine concentrations were decreased in hypothalamus and cortex in co- and post-treated folic acid groups with hypothyroid rats, while the concentration of dopamine were significantly increased in the hypothalamus and hippocampus of the hypothyroid rats and co-treated folic acid group with hypothyroid rats. In cortex, the dopamine concentration was significantly increased in hypothyroid rats and post-treated folic acid group with hypothyroid rats, while it significantly decreased in co-treated folic acid group with hypothyroid rats when compared with the control group. Also, our results revealed that, folic acid treatment was better if it is administered as an adjuvant after returning to the euthyroid state by withdrawing PTU from the drinking water.
authors.affiliation: Department of Zoology, Faculty of Science, Tanta University, Tanta, Egypt. toussonehab@yahoo.com
authors.forename: E
authors.initials: E
authors.lastname: Tousson
authors.forename: W
authors.initials: W
authors.lastname: Ibrahim
authors.forename: N
authors.initials: N
authors.lastname: Arafa
authors.forename: M A
authors.initials: MA
authors.lastname: Akela
mesh_terms: D000818:Animals; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D001923:Brain Chemistry; D002540:Cerebral Cortex / Q000187:drug effects / Q000378:metabolism; D002851:Chromatography, High Pressure Liquid; D004195:Disease Models, Animal; D004359:Drug Therapy, Combination; D005492:Folic Acid / Q000494:pharmacology*; D007031:Hypothalamus / Q000187:drug effects / Q000378:metabolism; D007037:Hypothyroidism / Q000139:chemically induced / Q000378:metabolism*; D008297:Male; D009638:Norepinephrine / Q000032:analysis / Q000378:metabolism*; D011441:Propylthiouracil / Q000633:toxicity; D051381:Rats; D012701:Serotonin / Q000032:analysis / Q000378:metabolism*; D013972:Thyrotropin / Q000097:blood; D014284:Triiodothyronine / Q000097:blood; D014803:Vitamin B Complex / Q000494:pharmacology*
chemical_list: D014284:Triiodothyronine; D014803:Vitamin B Complex; D012701:Serotonin; D011441:Propylthiouracil; D013972:Thyrotropin; D005492:Folic Acid; D009638:Norepinephrine